Treatment

Treatment of COVID-19

There is treatment against COVID-19 and it is out there for everyone. Information about this is fully blocked since spring of 2020.

Numerous international studies have shown that prophylactic and early treatment can significantly reduce the risk of severe and fatal covid-19 (see scientific references below).
Based on the available scientific evidence and current clinical experience, many scientists and medical experts consider the covid-19 treatments below for the prophylactic and early treatment of people at high risk or high exposure.
Nutrition and a Healthy Life Style
• Medication

Unfortunately the focus was on novel high-cost pharmaceutically engineered products such as Remdesivir, monoclonal antibodies, Tocilizumab, with all such therapies costing thousands of dollars. The focus was not on long-established drugs like Ivermectin, Hydroxychloroquine or others with very few side effects available at very low cost, which many physicians have used very successfully.
Incomprehensibly, these proven drugs had been banned for the treatment of Covid in hospitals all around the USA and in Western countries. In addition, Hydroxychloroquine / HCQ was recommended by the WHO at the beginning of the epidemic, but unfortunately with a far too high, lethal doses and far too late into the illness. When a Lancet Study published that Hydroxychloroquine was associated with decreased in-hospital survival,  WHO completely banned HCQ for the treatment of Covid. The Lancet Study later had to be retracted, because the data was allegedly fake. There is also the misconception that Ivermectin, or Hydroxychloroquine would be used as an exclusive treatment, but doctors who successfully treated their patients used those medications in combination with several other drugs.
So although treatment was available, it was banned and people were either sent home by the doctor or hospital only to come back when it was already too late. At that point many patients were put on ventilators – which was the next big mistake they made.
We just learned about the contracts Pfizer made with many countries. These contracts stipulated that even if a treatment for Covid-19 was found before the vaccines were delivered, the contracts would continue and countries would have to purchase the same amount of vaccines.
In addition, the EUA for vaccines depends on three factors:
1. There is an emergency
2. There is no other medication or treatment
3. The vaccines are safe & effective
So it’s a fair question to ask whether the contracts with the pharmaceutical industry and the pressure to approve the EUA’s led to the banning of the drugs.

Since we are no experts our collection of information offered as a convenience to the public is neither a recommendation nor a verification of providers, treatments or medical devices. Please find our disclaimer at the bottom of this page.

On the Treatment of Covid-19

Nutrition, supplements and an healthy and active lifestyle

The most important thing to do is to stay and maintain a healthy and active lifestyle. To accomplish this there are some things you can actively do on your own:

Stay active: Go for a brisk walk or jog outside in uncrowded areas outdoors. Push-ups, sit-ups, jumping-jacks and more exercises are great ways to stay fit.

Fresh Air & Sunshine: Lots of fresh air and sunshine. Being outside breathing fresh air and enjoying the sunshine is not only healthy for your body but also for your mind and keeps your immune system up.

Adequate sleep: Good sleep is essential to our overall health. According to The National Institutes of Health (NIH): “Immune system activation alters sleep, and sleep in turn affects the innate and adaptive arm of our body’s defense system.” The CDC recommends adults age 18-60 years get seven or more hours of sleep per night.

Diet and nutrition: Best is whole foods like dark, leafy greens, oranges and tomatoes—even fresh herbs—are loaded with vitamins, fiber and minerals. Make it a habit to try to eat more fresh, whole nutritious foods instead of processed snacks or fast food.

Self-care: Take time to take care of yourself. Meditation, relaxation, quality time with family, personal care of yourself promotes overall wellness.

Cope with stress and anxiety: Positive coping mechanisms would include exercise, meditation, reading, further developing certain skills or hobbies etc. Use this era to increase your daily repetition of these positive activities and develop new or even better routines.

Stay connected: Stay in touch with those you love, talk with friends and keep or make new connections.

Nutritions in addition to a Healthy Life Style

5/25/2021
Quercetin
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
Quercetin

12/1/2020
Vitamin D and COVID-19: evidence and recommendations for supplementation
Vitamin D

4/22/2019
The Role of Zinc in Antiviral Immunity
Zinc

5/1/2007
Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress
Zinc

Treatment

Treatment protocol

Prophylaxis

Vitamin D3 (2000 IU per day)
Zinc (20mg to 40mg per day)
Quercetin (250mg per day)
Bromhexine (24mg per day)*
Mouthwashes and nasal spray

Early treatment

Zinc (75mg to 100mg per day)
Quercetin (500mg per day)
Aspirin (325mg per day)*
Bromhexine (48mg per day)*
Mouthwashes and nasal spray

Prescription only

High-dose calcifediol*
Sulodexide (LMW heparin)*
Fluvoxamine or cyproheptadine*
Steroids: Prednisone or budesonide*
Monoclonal antibody treatment
Anti-androgen treatment
Ivermectin (see below)
(*) Notes

Bromhexine is available prescription-free in most of Europe, but not in the US.
Cyproheptadine and steroids are only used if respiratory symptoms develop.
Counterindications and maximum dosages must be observed for all drugs!

11/30/2020
Critical Care COVID-19 Management Protocol
Developed and updated by Paul Marik, MD, Chief of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, Norfolk, VA

Prophylaxis
■ Vitamin C 500 mg BID (twice daily) and Quercetin 250 mg daily
■ Vitamin D3 1000-4000 u/day
■ B complex vitamins
■ Zinc 30-50 mg/day
■ Melatonin (slow release): Begin with 0.3mg and increase as tolerated to 2 mg at night
■ Ivermectin for postexposure prophylaxis (200 ug/kg immediately, then repeat on day
3) and prophylaxis in high-risk groups (200 ug/kg day 1, then day 3 and then every 4
weeks)

Mildly Symptomatic patients (at home):
■ Ivermectin 150-200 ug/kg daily for two doses
■ Vitamin C 500mg BID and Quercetin 250-500 mg BID
■ Vitamin D3 2000 – 4000 u/day
■ B Complex vitamins
■ Zinc 75-100 mg/day
■ Melatonin 6-10 mg at night (the optimal dose is unknown)
■ ASA aspirin 81-325 mg/day (unless contraindicated)

In symptomatic patients, monitoring with home pulse oximetry is recommended.
Ambulatory desaturation below 94% should prompt hospital admission

Ivermectin

July/August 2021
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
Journal

July 2021
Ivermectin in COVID-19
“Ivermectin is a well-known, FDA-approved anti-parasite drug that has been used successfully for more than four decades to treat onchocerciasis “river blindness” and other parasitic diseases. It is one of the safest drugs known. It is on the WHO’s list of essential medicines, has been given 3.7 billion times around the globe, and has won the Nobel prize for its global and historic impacts in eradicating endemic parasitic infections in many parts of the world. Our medical discovery of a rapidly growing published medical evidence base, demonstrating ivermectin’s unique and highly potent ability to inhibit SARS-CoV-2 replication and to suppress inflammation, prompted our team to use ivermectin for prevention and treatment in all stages of COVID-19. Ivermectin is not yet FDA-approved for the treatment of COVID-19, but on Jan 14, 2021, the NIH changed their recommendation for the use of ivermectin in COVID-19 from “against” to “neutral”.”
Ivermectin


8/4/2021
Ivermectin

8/4/2021
COVID-19 early treatment:
Real-time analysis of 782 studies
Real-time analysis of 818 studies

8/4/2021
Ivermectin is effective for COVID-19:
Meta analysis of 26 studies
Meta analysis of 26 studies

7/14/2021
Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection
Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection

6/30/2021
Prevention & early outpatient treatment protocol for Covid-19
Prevention & early outpatient treatment protocol for Covid-19

June 15, 2021
The mechanisms of action of Ivermectin against SARS-CoV-2:
An evidence-based clinical review article
An evidence-based clinical review article

May/June 2021
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

5/31/2021
Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo-controlled trial can be found at the following
Ivermectin in early treatment of non-hospitalized patients with mild COVID-19

4/16/2021
Dr. George Fareed and Dr. Brian Tyson share early treatment protocol
early treatment protocol
Protocol

1/16/2021
Review of the Emerging Evidence Demonstrating the Efficacy of
Ivermectin in the Prophylaxis and Treatment of COVID-19
Efficacy of
Ivermectin

Summary

1/15/2021
NIH Revises Treatment Guidelines for
Ivermectin for the Treatment of COVID-19
Ivermectin is Now a Therapeutic Option for
Doctors & Prescribers
Treatment Guidelines for Ivermectin for the Treatment of COVID-19

1/5/2021
Ivermectin shows clinical benefits in mild to moderate COVID19:
A randomised controlled double blind dose response study in Lagos
A randomised controlled double blind dose response study in Lagos

December 2020/ January 2021
First country bans ivermectin, a lifesaver for Covid–will the US be next?
First country bans ivermectin

12/9/2020
PROPHYLAXIS & EARLY OUTPATIENT TREATMENT PROTOCOL FOR COVID-19
Protocol

12/27/2020
Ivermectin meta-analysis by Dr. Andrew Hill
Ivermectin meta-analysis

11/13/2020
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

Hydroxychloroquine

8/4/2021
HCQ / Hydroxychloroquine studies
Studies

8/4/2021
79% lower death rate in countries using HCQ early
Early treatment with hydroxychloroquine: a country-based analysis
Countries

January 2021
Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection

January 27, 2021
Pathophysiologic Basis and Clinical Rationale for Early Ambulatory Treatment of COVID-19

12/2020
Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
ScienceDirect

December 2020
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study
A retrospective case series study

10/23/2020
AMA rescinds statement against the use of HCQ for COVID-19 treatment
see: Handbook Addendum Page 18

AMA

9/9/2020
Retrospective 56 patients in Uganda, showing 25.6% faster recovery with HCQ. There was no ICU admission, mechanical ventilation, or death.
COVID-19 Treatments

9/2/2020
Retrospective 100 elderly nursing home patients, HCQ+AZ mortality 11.4% vs. control 61.9%, RR 0.18, p<0.001. Median age 85.
COVID-19 Treatments

8/27/2020
73% lower risk of COVID-19 with csDMARDs (HCQ-CQ-etc.)
COVID-19 Treatments

July 2020
White Paper on Hydroxychloroquine
White Paper

July 2020
White Paper on Hydroxychloroquine / Dr. Simone Gold, MD,JD
White Paper on Hydroxychloroquine


7/1/2020
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Hydroxychloroquine provided a 66% hazard ratio reduction, and hydroxychloroquine + azithromycin 71% compared to neither treatment
Treatment

6/30/2020
COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study
Study

6/30/2020
Risk Factors for Mortality in Patients with COVID-19 in New York City
Study

6/29/2020
Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection
Portugal Study
Results: 77 (0.29%) of 26,815 C19 positive patients and 1,215 (0.36%) of 333,489 negative patients were chronically treated with HCQ (P=0.04)
Conclusions: data suggest that chronic treatment with HCQ confer protection against C19 infectionData suggest that chronic treatment with HCQ confer protection against C19 infection
Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.

5/27/2020
Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis
Study

5/22/2020
There was the Lancet study which was based on the implausible Surgisphere database compliments of Sapan S Desai, MD
WHO recommended an end to HCQ use based on this study which later had to be retracted, because the data was allegedly fake
The retracted Lancet Study

Finally WHO recommended an end to HCQ use based on this study which later had to be retracted, because the data was allegedly fake.

Overall, there are more positive than negative studies.
The negative studies are mostly about treating very sick patients with very high dosages of HCQ which is known not to work.

Dr. Fauci (NAIDI Director) has effectively shut down the only RTC that could have proven the efficacy of #Hydroxychloroquine in symptomatic adult outpatients

This study had its enrollment cut from 2000 to 20 subjects

5/8/2020
Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients
Study

4/25/2020
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19
Study

IMPORTANT NOTICE AND DISCLAIMER:
All the information provided on this website regarding doctors, medical providers, treatments, medications, medical devises etc. is ONLY a collection of information offered as a convenience to interested members of the public and is neither a recommendation of the provider, treatments, medications, medical devises etc. nor a verification of the provider’s qualifications or practices, medical or otherwise the effectiveness, impact, side effects of a medication, treatments, medical devises etc. .
We are not scientists, or doctors and have not undertaken any investigation of the medical providers, treatments, medications, medical devises or the accuracy of the information provided herein. Accordingly, reliance on any such information provided herein is solely at your own risk. Your independent investigation and evaluation is therefore strongly advised. Neither the Covid-Crime.org nor any individual associated with Covid-Crime.org is responsible or liable for the use or misuse of the information provided herein, and your use thereof or of this website acknowledges and accepts these terms.

There is treatment against COVID-19 and it is out there for everyone.
Information about this is fully blocked since spring of 2020.
Listen to Doctor Peter McCullough, MD and his testimony to the Texas Senate HHS Committee on March 10, 2021.

December 8, 2020
Dr. Pierre Kory pleads to Senate to consider Ivermectin as treatment for Covid-19
Appearing as a witness Tuesday morning before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution”— Dr. Pierre Kory, President of the Frontline COVID-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly emerging medical evidence on Ivermectin.

December 8, 2020
United States Senate
Full Committee Hearing
Early Outpatient Treatment: An Essential Part of a COVID-19 Solution

12/27/2020
Ivermectin meta-analysis by Dr. Andrew Hill
Ivermectin meta-analysis

All information is deemed accurate but not guaranteed and should be independently verified.